CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 99 of 674
Non-Antibody Products
Page 99 of 674
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 5 mg | 21177-5 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 1 mg | 27029-1 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 10 mg | 27029-10 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 25 mg | 27029-25 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 5 mg | 27029-5 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 1 mg | 33166-1 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 10 mg | 33166-10 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 5 mg | 33166-5 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 10 mg | 21771-10 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 25 mg | 21771-25 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 5 mg | 21771-5 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 50 mg | 21771-50 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 1 mg | 37354-1 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 10 mg | 37354-10 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 5 mg | 37354-5 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 50 mg | 37354-50 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 1 mg | 10549-1 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 10 mg | 10549-10 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 5 mg | 10549-5 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 1 g | 21601-1 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 100 mg | 21601-100 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 250 mg | 21601-250 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 500 mg | 21601-500 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 1 mg | 33563-1 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 10 mg | 33563-10 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 5 mg | 33563-5 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 10 mg | 36578-10 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 25 mg | 36578-25 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 5 mg | 36578-5 | More Info |
| C10-200 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 10 mg | 40863-10 | More Info |
| C10-200 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 25 mg | 40863-25 | More Info |
| C10-200 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 5 mg | 40863-5 | More Info |
| C10-200 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 50 mg | 40863-50 | More Info |
| C9-200 | An ionizable cationic lipid; LNPs containing C9-200 and encapsulating EPO… | 1 mg | 40862-1 | More Info |
| C9-200 | An ionizable cationic lipid; LNPs containing C9-200 and encapsulating EPO… | 10 mg | 40862-10 | More Info |
| C9-200 | An ionizable cationic lipid; LNPs containing C9-200 and encapsulating EPO… | 25 mg | 40862-25 | More Info |
| C9-200 | An ionizable cationic lipid; LNPs containing C9-200 and encapsulating EPO… | 5 mg | 40862-5 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 1 mg | 31064-1 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 10 mg | 31064-10 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 5 mg | 31064-5 | More Info |
| CA-074 | A selective cathepsin B inhibitor (Kis = 0.0087, 75, and 233 µM for… | 1 mg | 24679-1 | More Info |
| CA-074 | A selective cathepsin B inhibitor (Kis = 0.0087, 75, and 233 µM for… | 500 µg | 24679-500 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 1 mg | 27598-1 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 10 mg | 27598-10 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 25 mg | 27598-25 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 5 mg | 27598-5 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 1 mg | 37300-1 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 10 mg | 37300-10 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 25 mg | 37300-25 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 5 mg | 37300-5 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 1 mg | 40256-1 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 10 mg | 40256-10 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 5 mg | 40256-5 | More Info |
| Cabazitaxel | A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… | 10 mg | 22262-10 | More Info |
| Cabazitaxel | A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… | 25 mg | 22262-25 | More Info |
| Cabazitaxel | A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… | 5 mg | 22262-5 | More Info |
| Cabazitaxel | A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… | 50 mg | 22262-50 | More Info |
| Cabazitaxel-d9 | An internal standard for the quantification of cabazitaxel by GC- or LC-MS | 1 mg | 28488-1 | More Info |
| Cabazitaxel-d9 | An internal standard for the quantification of cabazitaxel by GC- or LC-MS | 5 mg | 28488-5 | More Info |
| Cabergoline | A potent and selective dopamine D2 receptor agonist (Kis = 0.912 and 6,935… | 1 mg | 23934-1 | More Info |
| Cabergoline | A potent and selective dopamine D2 receptor agonist (Kis = 0.912 and 6,935… | 10 mg | 23934-10 | More Info |
| Cabergoline | A potent and selective dopamine D2 receptor agonist (Kis = 0.912 and 6,935… | 5 mg | 23934-5 | More Info |
| Cabergoline | A potent and selective dopamine D2 receptor agonist (Kis = 0.912 and 6,935… | 50 mg | 23934-50 | More Info |
| Cabergoline-d6 | An internal standard for the quantification of cabergoline by GC- or LC-MS | 1 mg | 31690-1 | More Info |
| Cabergoline-d6 | An internal standard for the quantification of cabergoline by GC- or LC-MS | 100 µg | 31690-100 | More Info |
| Cabergoline-d6 | An internal standard for the quantification of cabergoline by GC- or LC-MS | 250 µg | 31690-250 | More Info |
| Cabergoline-d6 | An internal standard for the quantification of cabergoline by GC- or LC-MS | 500 µg | 31690-500 | More Info |
| Cab45 (37-362) (human, recombinant) | Source: Recombinant human C-terminal V5- and His-tagged Cab45 expressed in… | 20 µg | 40822-20 | More Info |
| 4-CAB (hydrochloride) | An analog of PCA; inhibits the reuptake of serotonin (IC50 = 330 nM) and d… | 10 mg | 13893-10 | More Info |
| 4-CAB (hydrochloride) | An analog of PCA; inhibits the reuptake of serotonin (IC50 = 330 nM) and d… | 5 mg | 13893-5 | More Info |
| 4-CAB (hydrochloride) | An analog of PCA; inhibits the reuptake of serotonin (IC50 = 330 nM) and d… | 50 mg | 13893-50 | More Info |
| Cabotegravir | An HIV-1 integrase inhibitor (IC50 = 3 nM in a strand transfer assay); inh… | 10 mg | 27215-10 | More Info |
| Cabotegravir | An HIV-1 integrase inhibitor (IC50 = 3 nM in a strand transfer assay); inh… | 25 mg | 27215-25 | More Info |
| Cabotegravir | An HIV-1 integrase inhibitor (IC50 = 3 nM in a strand transfer assay); inh… | 5 mg | 27215-5 | More Info |
| Cabotegravir | An HIV-1 integrase inhibitor (IC50 = 3 nM in a strand transfer assay); inh… | 50 mg | 27215-50 | More Info |
| Cabotegravir-d5 | An internal standard for the quantification of cabotegravir by GC- or LC-MS | 1 mg | 31319-1 | More Info |
| CaCC(inh)-A01 | A non-selective inhibitor of CaCCs; blocks ATP-stimulated chloride conduct… | 10 mg | 21922-10 | More Info |
| CaCC(inh)-A01 | A non-selective inhibitor of CaCCs; blocks ATP-stimulated chloride conduct… | 25 mg | 21922-25 | More Info |
| CaCC(inh)-A01 | A non-selective inhibitor of CaCCs; blocks ATP-stimulated chloride conduct… | 5 mg | 21922-5 | More Info |
| CaCC(inh)-A01 | A non-selective inhibitor of CaCCs; blocks ATP-stimulated chloride conduct… | 50 mg | 21922-50 | More Info |
| Cacodylic Acid (sodium salt hydrate) | A reagent used in electron microscopy techniques; has been used to introdu… | 10 g | 22996-10 | More Info |
| Cacodylic Acid (sodium salt hydrate) | A reagent used in electron microscopy techniques; has been used to introdu… | 25 g | 22996-25 | More Info |
| Cacodylic Acid (sodium salt hydrate) | A reagent used in electron microscopy techniques; has been used to introdu… | 50 g | 22996-50 | More Info |
| Cadazolid | An oxazolidinone-type antibiotic; has activity against a panel of C. diffi… | 1 mg | 23030-1 | More Info |
| Cadazolid | An oxazolidinone-type antibiotic; has activity against a panel of C. diffi… | 10 mg | 23030-10 | More Info |
| Cadazolid | An oxazolidinone-type antibiotic; has activity against a panel of C. diffi… | 25 mg | 23030-25 | More Info |
| Cadazolid | An oxazolidinone-type antibiotic; has activity against a panel of C. diffi… | 5 mg | 23030-5 | More Info |
| CADD522 | An inhibitor of RUNX2-DNA binding; inhibits RUNX2 binding to OSE2 oligonuc… | 100 mg | 36679-100 | More Info |
| CADD522 | An inhibitor of RUNX2-DNA binding; inhibits RUNX2 binding to OSE2 oligonuc… | 25 mg | 36679-25 | More Info |
| CADD522 | An inhibitor of RUNX2-DNA binding; inhibits RUNX2 binding to OSE2 oligonuc… | 250 mg | 36679-250 | More Info |
| CADD522 | An inhibitor of RUNX2-DNA binding; inhibits RUNX2 binding to OSE2 oligonuc… | 5 mg | 36679-5 | More Info |
| Caerulein (acetate) | An oligopeptide; increases the flow rate of gastric juices as well as peps… | 1 mg | 24408-1 | More Info |
| Caerulein (acetate) | An oligopeptide; increases the flow rate of gastric juices as well as peps… | 500 µg | 24408-500 | More Info |
| Caerulomycin A | A fungal metabolite with antifungal and immunosuppressant activities; inhi… | 1 mg | 27625-1 | More Info |
| Caerulomycin A | A fungal metabolite with antifungal and immunosuppressant activities; inhi… | 5 mg | 27625-5 | More Info |
| 3-CAF | A synthetic CB; intended for forensic and research applications | 1 mg | 15962-1 | More Info |
| 3-CAF | A synthetic CB; intended for forensic and research applications | 10 mg | 15962-10 | More Info |
| 3-CAF | A synthetic CB; intended for forensic and research applications | 5 mg | 15962-5 | More Info |
| Cafestol | A natural diterpene which elevates serum cholesterol and triglycerides in… | 10 mg | 13999-10 | More Info |
| Cafestol | A natural diterpene which elevates serum cholesterol and triglycerides in… | 5 mg | 13999-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile